← Back to Search

Behavioural Intervention

SWET: Supervised Weight loss and Exercise Training for Rheumatoid Arthritis (SWET/CHAT Trial)

N/A

Waitlist Available

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 16 weeks

Awards & highlights

SWET/CHAT Trial Summary

This trial will explore whether a counseling health as treatment program or a supervised weight loss and exercise training program is better for older, obese people with rheumatoid arthritis.

Eligible Conditions

Rheumatoid Arthritis

SWET/CHAT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Metabolic Syndrome Severity Z-score (MSSc)

Secondary outcome measures

Disease Activity Score (DAS-28)

Physical Function as Measured by PROMIS (Patient-Reported Outcomes Measurement Information System) Questionnaire

SWET/CHAT Trial Design

2Treatment groups

Experimental Treatment

Group I: Supervised Weight loss and Exercise Training (SWET)Experimental Treatment1 Intervention

SWET includes supervised aerobic (3x/w) and resistance (2x/w) training plus a weekly weight loss session.

Group II: Counseling Health As Treatment (CHAT)Experimental Treatment1 Intervention

CHAT is a control arm designed to reflect traditional clinical counselling.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,363 Previous Clinical Trials

3,420,492 Total Patients Enrolled

11 Trials studying Rheumatoid Arthritis

2,130 Patients Enrolled for Rheumatoid Arthritis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

484 Previous Clinical Trials

1,086,821 Total Patients Enrolled

44 Trials studying Rheumatoid Arthritis

560,983 Patients Enrolled for Rheumatoid Arthritis

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,826 Total Patients Enrolled

9 Trials studying Rheumatoid Arthritis

624 Patients Enrolled for Rheumatoid Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide an update on the enrollment status of this research initiative?

"The data available on clinicaltrials.gov indicates that this particular trial is not presently seeking out patients even though it was posted initially on July 21st 2021 and updated recently in November of 2022. Nevertheless, there are 604 other studies actively enrolling participants currently."

Answered by AI

Is it possible for me to join this research trial?

"This clinical trial seeks 26 elderly individuals with rheumatoid arthritis. To be eligible, applicants must have internet access, seropositivity for either the rheumatoid factor or anti-citrullinated protein antibody and a BMI between 28 to 40 kg/m2. Additionally, radiographs should showcase erosions typically associated with RA."

Answered by AI

Does this trial accept individuals younger than 50 years of age?

"According to the inclusion criteria, individuals between the ages of 60 and 80 are eligible to participate in this clinical trial. In comparison, 69 trials target those below 18 years of age while 502 studies concentrate on adults older than 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk

2021. "Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04356183.